- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Arch Therapeutics Inc (ARTHQ)
Arch Therapeutics Inc stock price live, this page displays OTC ARTHQ stock exchange data. View the ARTHQ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Arch Therapeutics Inc real time stock price chart below.
What Is the Arch Therapeutics Inc Stock Price Today?
The Arch Therapeutics Inc stock price today is 0.0001.
What Is the Stock Symbol for Arch Therapeutics Inc?
The stock symbol for Arch Therapeutics Inc is ""ARTHQ.""
What Stock Exchange Does Arch Therapeutics Inc Trade On?
Arch Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Arch Therapeutics Inc a Good Stock to Buy?
Determining whether Arch Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARTHQ quote. (ISIN: US03939W2089)
What Is the Arch Therapeutics Inc Stock Price Today?
The Arch Therapeutics Inc stock price today is 0.0001.
What Is the Stock Symbol for Arch Therapeutics Inc?
The stock symbol for Arch Therapeutics Inc is ""ARTHQ.""
What Stock Exchange Does Arch Therapeutics Inc Trade On?
Arch Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Arch Therapeutics Inc a Good Stock to Buy?
Determining whether Arch Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARTHQ quote. (ISIN: US03939W2089)
OTC Markets
Currency in USD
0.0001
0.0000(0.00%)
Closed·
Fair Value
An estimate of a Arch Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0001
0.0001
52 wk Range
0.0001
0.8400
ARTHQ Scorecard
Full Analysis
Net income is expected to grow this year
Trading near 52-week Low
1/2
Fair Value
An estimate of a Arch Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00010.0001
52 wk Range
0.00010.8400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ARTHQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Arch Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Arch Therapeutics Inc Company Profile
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. It’s flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was incorporated in 2006 and is based in Framingham, Massachusetts. On April 18, 2025, Arch Therapeutics, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.
Compare ARTHQ to Peers and Sector
Metrics to compare | ARTHQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARTHQPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.7x | −0.5x | |
PEG Ratio | 0.00 | −0.20 | 0.00 | |
Price/Book | 0.0x | 2.3x | 2.6x | |
Price / LTM Sales | 0.0x | 2.7x | 3.3x | |
Upside (Analyst Target) | - | 42.5% | 43.5% | |
Fair Value Upside | Unlock | 6.6% | 6.9% | Unlock |
Earnings
Latest Release
Aug 19, 2024
EPS / Forecast
-1.44 / --
Revenue / Forecast
30.91K / --
FAQ
What Stock Exchange Does Arch Therapeutics Trade On?
Arch Therapeutics is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Arch Therapeutics?
The stock symbol for Arch Therapeutics is "ARTHQ."
What Is the Arch Therapeutics Market Cap?
As of today, Arch Therapeutics market cap is 444.44.
What Is Arch Therapeutics's Earnings Per Share (TTM)?
The Arch Therapeutics EPS (TTM) is -2.35.
From a Technical Analysis Perspective, Is ARTHQ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Arch Therapeutics Stock Split?
Arch Therapeutics has split 2 times.
How Many Employees Does Arch Therapeutics Have?
Arch Therapeutics has 8 employees.
What is the current trading status of Arch Therapeutics (ARTHQ)?
As of 07 Aug 2025, Arch Therapeutics (ARTHQ) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.84.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.